Discontinued — last reported Q1 '18
CMS Energy Allowance for Doubtful Accounts Receivable (Current) increased by 18.5% to $32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $29.00M to $32.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows relatively stable performance with a -1.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.00M | $24.00M | $20.00M | $20.00M | $24.00M | $26.00M | $27.00M | $26.00M | $27.00M | $26.00M | $21.00M | $23.00M | $23.00M | $22.00M | $23.00M | $29.00M | $30.00M | $28.00M | $27.00M | $32.00M |
| QoQ Change | — | -11.1% | -16.7% | +0.0% | +20.0% | +8.3% | +3.8% | -3.7% | +3.8% | -3.7% | -19.2% | +9.5% | +0.0% | -4.3% | +4.5% | +26.1% | +3.4% | -6.7% | -3.6% | +18.5% |
| YoY Change | — | — | — | — | -11.1% | +8.3% | +35.0% | +30.0% | +12.5% | +0.0% | -22.2% | -11.5% | -14.8% | -15.4% | +9.5% | +26.1% | +30.4% | +27.3% | +17.4% | +10.3% |